What young men need to know about testicular cancer

Nov 19, 2020 | Jennifer O'Hara | @jenohara


While testicular cancer is rare compared with other types of cancer, it is the most common cancer in American males ages 15 to 35. Testicular cancer is highly treatable, even when cancer has spread beyond the testicle. Several treatments or a combination of treatments are available, and long-term survival rates are greater than 90%.

As a part of men's health and the Movember Foundation's focus on testicular cancer, Dr. Matthew Ziegelmann, a Mayo Clinic urologist, joins the Mayo Clinic Q&A podcast to discuss diagnosis and treatment of testicular cancer

To practice safe social distancing during the COVID-19 pandemic, this interview was conducted using video conferencing. The sound and video quality are representative of the technology used. For the safety of its patients, staff and visitors, Mayo Clinic has strict masking policies in place. Anyone shown without a mask was recorded prior to COVID-19 or recorded in an area not designated for patient care, where social distancing and other safety protocols were followed.

Connect with others talking about men's health and supporting one another in the Men's Health support group.

Interested in more newsfeed posts like this? Go to the Podcasts blog.

Please sign in or register to post a reply.
  Request Appointment